Skip to main content
Top
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Malaria | Correction

Correction to: Climate-proofing a malaria eradication strategy

Authors: Hannah Nissan, Israel Ukawuba, Madeleine Thomson

Published in: Malaria Journal | Issue 1/2021

Login to get access

Excerpt

Following publication of the original article [1], it was brought to our attention that the entries under the section ‘Practical recommendations' had not been numbered, when they should have been numbered as follows:
1.
Begin with managing short-term climate risks to control and elimination activities
 
2.
Incorporate climate into monitoring and evaluation of malaria control efforts
 
3.
Invest in monitoring and surveillance systems for climate and malaria
 
4.
Iteratively review and update malaria eradication strategies
 
5.
Long-term investments
 
6.
Build capacity and partnerships
 
Metadata
Title
Correction to: Climate-proofing a malaria eradication strategy
Authors
Hannah Nissan
Israel Ukawuba
Madeleine Thomson
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Malaria
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-021-03747-6

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine